title: Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone.
authors.forename: Noriko
authors.initials: N
authors.lastname: Satoh
authors.forename: Akira
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Akihiro
authors.initials: A
authors.lastname: Himeno
authors.forename: Yousuke
authors.initials: Y
authors.lastname: Sasaki
authors.forename: Hajime
authors.initials: H
authors.lastname: Yamakage
authors.forename: Kazunori
authors.initials: K
authors.lastname: Yamada
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Suganami
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Ogawa
mesh_terms: D015214:Antigens, Differentiation, Myelomonocytic / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D016753:Interleukin-10 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000276:immunology*; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000276:immunology*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000494:pharmacology* / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D015214:Antigens, Differentiation, Myelomonocytic; D007004:Hypoglycemic Agents; D015850:Interleukin-6; D018950:Lipopolysaccharide Receptors; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D000077205:Pioglitazone